An update on the nonoperative treatment of patients with metastatic bone disease.
Bone metastases constitute a major problem in oncology because of their frequency and the therapeutic problems they present. Treatment indications depend on accurate diagnosis including histologic type, number, location, and sensitivity to treatment. New findings in the pathophysiology of bone metastases, new staging procedures, new treatment modalities, and better guidelines improve therapeutic effectiveness and the quality of life of patients. There are biologic and biomechanical indications for treatment. The goals of treatment are pain relief, restoration and maintenance of function, and the prevention of complications. The nonsurgical treatment of patients with metastatic bone disease includes analgesics, hormones, radiation therapy, cytotoxic drugs, radiopharmaceuticals, chemoablation, vertebroplasty, and bisphosphonates. The future of the treatment of patients with metastatic bone disease may involve the identification of biochemical markers. The author presents an overview of the current scientific concepts of metastatic bone disease and indications and specific strategies for nonoperative treatment of patients with tumor-induced osteolysis from metastatic bone disease.
Schachar
N S
NS
Department of Surgery, Faculty of Medicine, University of Calgary, Alberta, Canada.
D001695:Biology; D014408:Biomarkers, Tumor / Q000032:analysis; D001696:Biomechanical Phenomena; D001859:Bone Neoplasms / Q000473:pathology / Q000503:physiopathology / Q000556:secondary* / Q000628:therapy; D002985:Clinical Protocols; D006801:Humans; D009367:Neoplasm Staging; D011788:Quality of Life; D016896:Treatment Outcome
D014408:Biomarkers, Tumor